Account
Inquiry
Tirzepatide 20mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This pharmaceutical grade compound is supplied as a white lyophilized powder with 99% purity, specifically designed for research purposes.
As a GLP-1/GIP dual agonist, Tirzepatide 20mg demonstrates multiple physiological effects including stimulation of insulin secretion, inhibition of glucagon release, delayed gastric emptying, and appetite suppression. These properties make it particularly interesting for metabolic disorder research.
The compound features a modified peptide sequence with PEGylation that enhances water solubility and extends half-life. Research suggests Tirzepatide 20mg may offer superior glycemic control and weight loss effects compared to single GLP-1 receptor agonists.
Potential research applications of Tirzepatide 20mg include: investigation of type 2 diabetes mechanisms, obesity treatment studies, metabolic syndrome research, and exploration of cardiovascular protection in diabetic models.
This product is supplied in lyophilized form for research use only. Proper storage at -20°C is recommended to maintain stability. Researchers should reconstitute with appropriate sterile solutions for experimental use.
Our manufacturing facility produces Tirzepatide 20mg under strict quality control standards. We offer bulk quantities for research institutions and custom synthesis options for specialized research needs.
